Cargando…

Evaluation of the efficacy of oxidized cellulose (surgicel) in reducing blood loss in suprapubic simple open prostatectomy: A randomized clinical trial

BACKGROUND: Simple open prostatectomy is still the treatment of choice for removing large prostates; however, peri-surgical bleeding accompanied by this technique has always been a challenge for urologist surgeons. Therefore, the present study aimed to investigate the effect of surgicel on reducing...

Descripción completa

Detalles Bibliográficos
Autores principales: Kazemi, Reza, Gholipour, Farshad, Salehi, Hanieh, Sichani, Mehrdad Mohammadi, Behnamfar, Amir, Fathi, Majid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199368/
https://www.ncbi.nlm.nih.gov/pubmed/37213452
http://dx.doi.org/10.4103/jrms.jrms_618_22
_version_ 1785044917909716992
author Kazemi, Reza
Gholipour, Farshad
Salehi, Hanieh
Sichani, Mehrdad Mohammadi
Behnamfar, Amir
Fathi, Majid
author_facet Kazemi, Reza
Gholipour, Farshad
Salehi, Hanieh
Sichani, Mehrdad Mohammadi
Behnamfar, Amir
Fathi, Majid
author_sort Kazemi, Reza
collection PubMed
description BACKGROUND: Simple open prostatectomy is still the treatment of choice for removing large prostates; however, peri-surgical bleeding accompanied by this technique has always been a challenge for urologist surgeons. Therefore, the present study aimed to investigate the effect of surgicel on reducing bleeding in trans-vesical prostatectomy. MATERIALS AND METHODS: The present double-blinded clinical trial included 54 patients with Benign Prostatic Hyperplasia (BPH), divided into two groups of 27, and underwent trans-vesical prostatectomy. After removing the prostate, the prostate adenoma was weighed in the first group. Then, two surgicel were inserted into the prostate loge for prostate adenomas weighing 75 g or less. For larger prostates, another surgicel was inserted for each 25 g weight higher than the limit of 75 g. However, no Surgicel was inserted in the control group. Other steps of the procedure were the same in both groups. Moreover, hemoglobin and hematocrit levels were assessed in both groups; preoperation, intra-operative, 24 h, and 48 h postoperative. In addition, all the fluid used for bladder irrigation was collected, and its hemoglobin level was assessed. RESULTS: According to our results, no intergroup difference in hemoglobin level changes, hematocrit changes, International Prostate Symptom Score (IPSS), postoperative hospital stay, and number of packed cells received. However, the postoperative blood loss in bladder lavage fluid was significantly higher in the control group (120.83 ± 46.66 g) as compared to the surgicel group (72.56 ± 32.53 g) (P < 0.001). CONCLUSION: The present study concluded that using surgicel in trans-vesical prostatectomy could reduce postoperative bleeding without increasing the chance of postoperative complications.
format Online
Article
Text
id pubmed-10199368
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-101993682023-05-21 Evaluation of the efficacy of oxidized cellulose (surgicel) in reducing blood loss in suprapubic simple open prostatectomy: A randomized clinical trial Kazemi, Reza Gholipour, Farshad Salehi, Hanieh Sichani, Mehrdad Mohammadi Behnamfar, Amir Fathi, Majid J Res Med Sci Original Article BACKGROUND: Simple open prostatectomy is still the treatment of choice for removing large prostates; however, peri-surgical bleeding accompanied by this technique has always been a challenge for urologist surgeons. Therefore, the present study aimed to investigate the effect of surgicel on reducing bleeding in trans-vesical prostatectomy. MATERIALS AND METHODS: The present double-blinded clinical trial included 54 patients with Benign Prostatic Hyperplasia (BPH), divided into two groups of 27, and underwent trans-vesical prostatectomy. After removing the prostate, the prostate adenoma was weighed in the first group. Then, two surgicel were inserted into the prostate loge for prostate adenomas weighing 75 g or less. For larger prostates, another surgicel was inserted for each 25 g weight higher than the limit of 75 g. However, no Surgicel was inserted in the control group. Other steps of the procedure were the same in both groups. Moreover, hemoglobin and hematocrit levels were assessed in both groups; preoperation, intra-operative, 24 h, and 48 h postoperative. In addition, all the fluid used for bladder irrigation was collected, and its hemoglobin level was assessed. RESULTS: According to our results, no intergroup difference in hemoglobin level changes, hematocrit changes, International Prostate Symptom Score (IPSS), postoperative hospital stay, and number of packed cells received. However, the postoperative blood loss in bladder lavage fluid was significantly higher in the control group (120.83 ± 46.66 g) as compared to the surgicel group (72.56 ± 32.53 g) (P < 0.001). CONCLUSION: The present study concluded that using surgicel in trans-vesical prostatectomy could reduce postoperative bleeding without increasing the chance of postoperative complications. Wolters Kluwer - Medknow 2023-04-20 /pmc/articles/PMC10199368/ /pubmed/37213452 http://dx.doi.org/10.4103/jrms.jrms_618_22 Text en Copyright: © 2023 Journal of Research in Medical Sciences https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Kazemi, Reza
Gholipour, Farshad
Salehi, Hanieh
Sichani, Mehrdad Mohammadi
Behnamfar, Amir
Fathi, Majid
Evaluation of the efficacy of oxidized cellulose (surgicel) in reducing blood loss in suprapubic simple open prostatectomy: A randomized clinical trial
title Evaluation of the efficacy of oxidized cellulose (surgicel) in reducing blood loss in suprapubic simple open prostatectomy: A randomized clinical trial
title_full Evaluation of the efficacy of oxidized cellulose (surgicel) in reducing blood loss in suprapubic simple open prostatectomy: A randomized clinical trial
title_fullStr Evaluation of the efficacy of oxidized cellulose (surgicel) in reducing blood loss in suprapubic simple open prostatectomy: A randomized clinical trial
title_full_unstemmed Evaluation of the efficacy of oxidized cellulose (surgicel) in reducing blood loss in suprapubic simple open prostatectomy: A randomized clinical trial
title_short Evaluation of the efficacy of oxidized cellulose (surgicel) in reducing blood loss in suprapubic simple open prostatectomy: A randomized clinical trial
title_sort evaluation of the efficacy of oxidized cellulose (surgicel) in reducing blood loss in suprapubic simple open prostatectomy: a randomized clinical trial
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199368/
https://www.ncbi.nlm.nih.gov/pubmed/37213452
http://dx.doi.org/10.4103/jrms.jrms_618_22
work_keys_str_mv AT kazemireza evaluationoftheefficacyofoxidizedcellulosesurgicelinreducingbloodlossinsuprapubicsimpleopenprostatectomyarandomizedclinicaltrial
AT gholipourfarshad evaluationoftheefficacyofoxidizedcellulosesurgicelinreducingbloodlossinsuprapubicsimpleopenprostatectomyarandomizedclinicaltrial
AT salehihanieh evaluationoftheefficacyofoxidizedcellulosesurgicelinreducingbloodlossinsuprapubicsimpleopenprostatectomyarandomizedclinicaltrial
AT sichanimehrdadmohammadi evaluationoftheefficacyofoxidizedcellulosesurgicelinreducingbloodlossinsuprapubicsimpleopenprostatectomyarandomizedclinicaltrial
AT behnamfaramir evaluationoftheefficacyofoxidizedcellulosesurgicelinreducingbloodlossinsuprapubicsimpleopenprostatectomyarandomizedclinicaltrial
AT fathimajid evaluationoftheefficacyofoxidizedcellulosesurgicelinreducingbloodlossinsuprapubicsimpleopenprostatectomyarandomizedclinicaltrial